InvestorsHub Logo
Followers 65
Posts 23975
Boards Moderated 0
Alias Born 11/23/2016

Re: None

Monday, 10/16/2023 11:39:26 AM

Monday, October 16, 2023 11:39:26 AM

Post# of 463629
Regarding Kun Jin joining Anavex and the WGT script.

It’s good to see he joined. Perhaps it improves the chances, but it isn’t synonymous with Anavex being guaranteed Accelerated Approval based on the P2b/3 trial.

Kun Jin joining will benefit future trial designs and regulatory submissions. Timing of joining Anavex is perfect for that with all of the long promised trials still to be initiated. Important to get those designs and the SAP for them nailed up front and avoid the last minute fumbles.

Retirement from the FDA and landing a good job with a promising biotech is a bonus on top of nice public pension and will likely benefit all involved.

No need or reason to read into it any more or less than that.

This is also completely consistent with my long held view that Anavex stand to eventually succeed in some indication by designing actual Precision Medicine trials selecting for responders based on everything learned.

Rett remains the focus at present and imo represents the best chance of a first approval.

The longer we wait, the sooner we will get rich!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News